Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer
Public ClinicalTrials.gov record NCT03733210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot Study Evaluating Panitumumab-IRDye800 and 89Zr-Panitumumab for Dual-Modality Imaging for Nodal Staging in Head and Neck Cancer
Study identification
- NCT ID
- NCT03733210
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Andrei Iagaru
- Other
- Enrollment
- 14 participants
Conditions and interventions
Interventions
- 89-Zirconium (Zr-89) Panitumumab Drug
- Da Vinci Firefly Imaging System Device
- Explorer Air camera Device
- FIS-00 fluorescence imaging system (FIS) Device
- IGP-ELVIS-v4 Macroscopic Specimen Imager Device
- Leica fluorescence microscope Device
- Odyssey CLx Imaging System Device
- PDE-NEO II camera Device
- Panitumumab-IRDye800 Drug
- Pearl Triology Imaging System Device
- Pinpoint IR IR9000 fluorescence imaging system (FIS) Device
- SPY-PHI IR9000 fluorescence imaging system (FIS) Device
- Vevo 3100 LAZR-X Device
Drug · Device
Eligibility (public fields only)
- Age range
- 19 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 6, 2019
- Primary completion
- Dec 10, 2020
- Completion
- Aug 8, 2021
- Last update posted
- May 18, 2023
2019 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford Cancer Institute Palo Alto | Palo Alto | California | 94304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03733210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2023 · Synced May 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03733210 live on ClinicalTrials.gov.